Bone mineral density before and after surgical cure of Cushing's syndrome due to adrenocortical adenoma: Prospective study

World Journal of Surgery

Volumn 32, Issue 5, 2008, Pages 890-896

  Kawamata, Akiko ^a   Iihara, Masatoshi ^a   Okamoto, Takahiro ^a   Obara, Takao ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENAL CORTEX ADENOMA; ADRENALECTOMY; ADULT; ARTICLE; BONE DENSITY; CHRONOLOGY; CLINICAL ARTICLE; CUSHING SYNDROME; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; GENERAL CONDITION IMPROVEMENT; HUMAN; HYPERCORTISOLISM; LAPAROSCOPIC SURGERY; LONGITUDINAL STUDY; LUMBAR SPINE; MALE; MEDICAL ASSESSMENT; POSTMENOPAUSE; POSTOPERATIVE PERIOD; PREMENOPAUSE; PREOPERATIVE EVALUATION; PROSPECTIVE STUDY; SECONDARY OSTEOPOROSIS; SURGICAL PATIENT; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL ADENOMA; ADULT; AGE FACTORS; BONE DENSITY; BONE REMODELING; CUSHING SYNDROME; FEMALE; FEMUR; HUMANS; LONGITUDINAL STUDIES; LUMBAR VERTEBRAE; MALE; MENOPAUSE; SEX FACTORS; TREATMENT OUTCOME;

EID: 42449087204     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-007-9394-7     Document Type: Article

References (34)

1. Cushing H (1932) The basophil adenomas of the pituitary body and their clinical manifestation (pituitary basophilism). Bull Johns Hopkins Hosp 50:137-195
2. Minetto M, Reimondo G, Osella G, et al. (2004) Bone loss is more severe in primary adrenal than pituitary-dependent Cushing's syndrome. Osteoporos Int 15:855-861
3. Ohmori N, Nomura K, Ohmori K, et al. (2003) Osteoporosis is more prevalent in adrenal than in pituitary Cushing's syndrome. Endocr J 50:1-7
4. Kaltsas G, Manetti L, Grossman AB (2002) Osteoporosis in Cushing's syndrome. Front Horm Res 30:60-72
5. Lane NE, Lukert B (1998) The science and therapy of glucocorticoid- induced bone loss. Endocrinol Metab Clin North Am 27:465-483
6. Osella G, Reimondo G, Peretti P, et al. (2001) The patients with incidentally discovered adrenal adenoma (incidentaloma) are not at increased risk of osteoporosis. J Clin Endocrinol Metab 86:604-607
7. Manelli F, Giustina A (2000) Glucocorticoid-induced osteoporosis. Trends Endocrinol Metab 11:79-85
8. Vestergaard P, Lindholm J, Jorgensen JOL, et al. (2002) Increased risk of osteoporotic fractures in patients with Cushing's syndrome. Eur J Endocrinol 146:51-56
9. Canalis E (1996) Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrinol Metab 81:3441-3447
10. Lukert BP, Raisz LG (1990) Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 112:352-364
11. Reid IR (2000) Glucocorticoid-induced osteoporosis. Baillieres Best Pract Res Clin Endocrinol Metab 14:279-298
12. Kristo C, Jemtland R, Ueland T, et al. (2006) Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing's syndrome: a prospective, long-term study. Eur J Endocrinol 154:109-118
13. Tatiana M, Mauro D, Gherardo M, et al. (2004) Cushing's syndrome and bone. Pituitary 7:243-246
14. Karavitaki N, Loannidis G, Giannakopoulos F, et al. (2004) Evaluation of bone mineral density of the peripheral skeleton in pre- and postmenopausal women with newly diagnosed endogenous Cushing's syndrome. Clin Endocrinol (Oxf) 60:264-270
15. Luisetto G, Zangari M, Camozzi V, et al. (2001) Recovery of bone mineral density after surgical cure, but not by ketoconazole treatment, in Cushing's syndrome. Osteoporosis Int 12:956-960
16. Hermus AR, Smals AG, Swinkels LM, et al. (1995) Bone mineral density and bone turnover before and after surgical cure of Cushing's syndrome. J Clin Endocrinol Metab 80:2859-2865
17. Hermus AR, Huysmans DA, Smals AG, et al. (1994) Remarkable improvement of osteopenia after cure of Cushing's syndrome. Horm Metab Res 26:209-210
18. Manning PJ, Evans MC, Reid IR (1992) Normal bone mineral density following cure of Cushing's syndrome. Clin Endocrinol (Oxf) 36:229-234
19. Pocock NA, Eisman JA, Dunstan CR, et al. (1987) Recovery from steroid-induced osteoporosis. Ann Intern Med 107:319-323
20. Lufkin EG, Wahner HW (1988) Reversibility of steroid-induced osteoporosis. Am J Med 85:887-888
21. Anonymous (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. World Health Organ Tech Rep Ser 843:1-129
22. Chiodini I, Carnecale V, Torlontano M, et al. (1998) Alterations of bone turnover and bone mass at different skeletal sites due to pure glucocorticoid excess: study in eumenorrheic patients with Cushing's syndrome. J Clin Endocrinol Metab 83:1863-1867
23. Francucci CM, Pantanetti P, Garrapa GG, et al. (2002) Bone metabolism and mass in women with Cushing's syndrome and adrenal incidentaloma. Clin Endocrinol (Oxf) 57:587-593
24. Kaplan FS, Leone VJ, Fallon MD, et al. (1987) Multiple pathologic fractures of the appendicular skeleton in a patient with Cushing's disease. Clin Orthop 216:171-175
25. Reid IR, Gray AB (1993) Corticosteroid osteoporosis. Baillieres Clin Rheumatol 7:573-587
26. Tauchmanova L, Rossi R, Nuzzo V, et al. (2001) Bone loss determined by quantitative ultrasonometry correlates inversely with disease activity in patients with endogenous glucocorticoid excess due to adrenal mass. Eur J Endocrinol 145:241-247
27. Reid IR, Evans MC, Stapleton J (1992) Lateral spine densitometry is a more sensitive indicator of glucocorticoid-induced bone loss. J Bone Miner Res 7:1221-1225
28. Mazess RB, Gifford CA, Bisek JP, et al. (1991) DEXA measurement of spine density in the lateral projection. Calcif Tissue Int 49:235-239
29. Rupich R, Pacifici R, Griffin M, et al. (1990) Lateral dual energy radiography: a new method for measuring vertebral bone density: a preliminary study. J Clin Endocrinol Metab 70:1768-1770
30. Iacobone M, Mantero F, Basso SM, et al. (2005) Results and long-term follow-up after unilateral adrenalectomy for ACTH-independent hypercortisolism in a series of fifty patients. J Endocrinol Invest 28:327-332
31. Godang K, Ueland T, Bollerslev J (1999) Decreased bone area, bone mineral content, formative markers, and increased bone resorptive markers in endogenous Cushing's syndrome. Eur J Endocrinol 141:126-131
32. Ebeling PR, Peterson JM, Riggs BL (1992) Utility of type I procollagen propeptide assays for assessing abnormalities in metabolic bone diseases. J Bone Miner Res 7:1243-1249
33. Piovesan A, Terzolo M, Reimondo G, et al. (1994) Biochemical markers of bone and collagen turnover in acromegaly or Cushing's syndrome. Horm Metab Res 26:234-237
34. Sartorio A, Conti A, Ferrero S, et al. (1998) Evaluation of markers of bone and collagen turnover in patients with active and preclinical Cushing's syndrome and in patients with adrenal incidentaloma. Eur J Endocrinol 138:146-152